{
    "code": "51058065",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058065",
    "time": "2018-12-28 03:46:58",
    "許可證字號": "衛部藥製字第058065號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/08\/30",
    "發證日期": "102\/08\/30",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY05105806502",
    "中文品名": "多西20毫克\/毫升單支注射液",
    "英文品名": "Doce Injection 20mg\/ml, 1ml\/vial",
    "適應症": "乳癌、非小細胞肺癌、前列腺癌、胃腺癌、頭頸癌。",
    "劑型": "270注射劑",
    "包裝": "1毫升玻璃小瓶裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DOCETAXELANHYDROUS"
    ],
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "1119206200  健亞生物科技股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1119206300  健亞生物科技股份有限公司",
        "製造廠廠址": "新竹縣湖口鄉新竹工業區工業一路１號",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013000220",
            "成分名稱": "DOCETAXEL ANHYDROUS",
            "含量描述": "Docetaxel Trihydrate (equivalent to docetaxel (anhydrous)",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Doce-Insert-106-12-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058065&Seq=006&Type=9"
        },
        {
            "title": "IT15202 反-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058065&Seq=005&Type=9"
        },
        {
            "title": "Doce-Label-106-12-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058065&Seq=005&Type=8"
        },
        {
            "title": "Doce-Carton-106-12-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058065&Seq=004&Type=8"
        },
        {
            "title": "CN25402 Doce-104-09-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058065&Seq=003&Type=8"
        }
    ]
}